Evaluation of the new prostate biopsy strategy for the detection of the prostate significant cancer

Evaluation of the new prostate biopsy strategy for the detection of the prostate significant cancer - Evaluation of the new prostate biopsy strategy for the detection of the prostate significant cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042475

Enrollment

200

Registered

2020-11-17

Start date

2020-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer suspected

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Person whose serum PSA level of 20ng/ml or less. 2.Person who can undergo a transrectal prostate biopsy. 3.Person who has been diagnosed prostate cancer by transrectal biopsy and have undergone radical prostatectomy. 4.Person who agree with informed consent.

Exclusion criteria

Exclusion criteria: 1.Person who have difficulty inserting a transrectal ultrasound probe due to anal stenosis. 2.Person who are regarded as inappropriate for the study by the researcher.

Design outcomes

Primary

Measure	Time frame
Detection rate of significant cancer in prostatectomy specimens	—

Countries

Japan

Contacts

Public ContactTaro Higure

Tokai University School of Medicine

t_higure0415@yahoo.co.jp0463-93-1121

Outcome results